Item 1A. Risk Factors.
Refer to Part I, Item 1A: Risk Factors on pages 10–37 of JPMorganChase’s 2024 Form 10-K and Forward-Looking Statements on page 91 of this Form 10-Q for a discussion of certain risk factors affecting the Firm.
Supervision and regulation
Refer to the Supervision and regulation section on pages 2-7 of JPMorganChase’s 2024 Form 10-K for information on Supervision and Regulation.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
 
Repurchases under the common share repurchase program
Refer to Capital Risk Management on pages 44-50 of this Form 10-Q and pages 97–107 of JPMorganChase’s 2024 Form 10-K for information regarding repurchases under the Firm’s common share repurchase program.
On July 1, 2025, the Firm announced that its Board of Directors had authorized a new $50 billion common share repurchase program, effective July 1, 2025. Through June 30, 2025, the Firm was authorized to purchase up to $30 billion of common shares under its previously-approved common share repurchase program that was announced on June 28, 2024.
203
Shares repurchased pursuant to the common share repurchase program during the nine months ended
 
September 30, 2025 were as follows:
Nine months ended September 30, 2025
Total number of shares of common stock repurchased
Average price paid per share of common stock
(a)
Aggregate purchase price of common stock repurchases
 (in millions)
(a)
Dollar value of remaining authorized repurchase
(in millions)
(a)
First qua

--- CHUNK ---

Barnum
Chief Financial Officer
August 6, 2025
August 6, 2025 – March 31, 2026
50% of the net issued shares received as a result of RSUs vesting on January 13, 2026
Lori Beer
Chief Information Officer
August 8, 2025
August 8, 2025 – March 31, 2026
50% of the net issued shares received as a result of RSUs vesting on January 13, 2026
Mary Erdoes
CEO, AWM
August 1, 2025
August 1, 2025 – March 31, 2026
50% of the net issued shares received as a result of RSUs vesting on January 13, 2026
Stacey Friedman
(a)
General Counsel
August 14, 2025
August 14, 2025 – March 31, 2026
50% of the net issued shares received as a result of RSUs vesting on January 13, 2026
Marianne Lake
(b)
CEO, CCB
August 13, 2025
August 13, 2025 – March 31, 2026
50% of the net issued shares received as a result of RSUs vesting on January 13, 2026
Robin Leopold
Head of Human Resources
August 8, 2025
August 8, 2025 – March 31, 2026
966
Douglas Petno
Co-CEO, CIB
August 11, 2025
August 11, 2025 – March 31, 2026
50% of the net issued shares received as a result of RSUs vesting on January 13, 2026
Jennifer Piepszak
Chief Operating Officer
July 25, 2025
July 25, 2025 – March 31, 2026
50% of the net issued shares received as a result of RSUs vesting on January 13, 2026
(a)
Transaction by trust of which Ms. Friedman has either a direct or indirect pecuniary interest.
(b)
Transaction by trust of which Ms. Lake has either a direct or indirect pecuniary interest.
(c)
Sales under the trading arrangement will not commence until

--- CHUNK ---

eptember 16, 202
5
.
(a)
3.2
B
y-laws of J
P
Morgan Chase & Co., as amended, effec
tive Sept
ember 
12
, 202
5
 (
incor
porated by re
ference to Exhibit 3.
2
 to the Current Report on
 
Form 8-K of J
PM
organ Ch
a
se & Co. (File No. 1-5805) filed S
eptember 
1
2, 202
5
).
15
Letter re: Unaudited Interim Financial Information.
(a)
22
Subsidiary Guarantors and Issuers of Guaranteed Securities
.
(a)
31.1
Certification.
(a)
31.2
Certification.
(a)
32
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(b)
101.INS
The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
(c)
101.SCH
XBRL Taxonomy Extension Schema Document.
(a)
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document.
(a)
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document.
(a)
101.LAB
XBRL Taxonomy Extension Label Linkbase Document.
(a)
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document.
(a)
104
Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).
(a)
Filed herewith.
(b)
Furnished herewith. This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.
(c)
Pursuant to Rule 405 of Regulation S-T, includes the fo